์๋ฏธ๋ ธํ๋ฆฐ / ํ ์คํ๋ฆฐ
์๋ฏธ๋ ธํ๋ฆฐ๊ณผ ํ ์คํ๋ฆฐ์ ์์ํ์์ ์ฃผ๋ก ๊ฐ๋ ฅํ ๊ธฐ๊ด์ง ํ์ฅ ํจ๊ณผ๋ฅผ ์ํด ์ฌ์ฉ๋๋ **๋ฉํธ์ํด ์ ๋์ฒด**์ ๋๋ค. ๊ณ ์์ด ์ฒ์, ๋ง์ ์ฌ๋ฐ์ฑ ๊ธฐ๋ ํ์(RAO), ๊ฐ์ ๊ธฐ๊ด์ง์ผ๊ณผ ๊ฐ์ ํ๋ถ ํธํก๊ธฐ ์งํ, ๊ธฐ๊ด ํํ์ ๊ด๋ฆฌ ๋ฐ ์ฌ์ธ์ฑ ํ๋ถ์ข ์ ๋ณด์กฐ ์๋ฒ์ผ๋ก ์์ฃผ ์ฌ์ฉ๋ฉ๋๋ค. > **์์ ์์ :** ์๋ฏธ๋ ธํ๋ฆฐ์ ๋ณธ์ง์ ์ผ๋ก ์ํธ๋ ๋์๋ฏผ์ ์ฒจ๊ฐํ์ฌ ๋ง๋ ํ ์คํ๋ฆฐ์ ์์ฉ์ฑ ์ผ์ ๋๋ค. **100mg์ ํจ์ ์๋ฏธ๋ ธํ๋ฆฐ์๋ ์ฝ 79mg์ ๋ฌด์ ํ ์คํ๋ฆฐ์ด ํฌํจ๋์ด ์์ต๋๋ค.** ๋ ํํ ์ฌ์ด๋ฅผ ๋ณ๊ฒฝํ ๋๋ ์ฉ๋ ๋ณํ์ ์ฃผ์ ๊น๊ฒ ๊ณ์ฐํด์ผ ํฉ๋๋ค. ์ด ์ฝ๋ฌผ๋ค์ ๋งค์ฐ ํจ๊ณผ์ ์ด์ง๋ง **์น๋ฃ ์ง์๊ฐ ์ข์ต๋๋ค**. ๋ ์ฑ์ ์ฉ๋์ ๋น๋กํ์ง๋ง, ๊ฐ์ ๊ณ ์์ด๋ ์ผ๋ฐ์ ์ผ๋ก ์ฌ๋๋ณด๋ค ๋์ ํ์ฒญ ๋๋๋ฅผ ์ ๊ฒฌ๋๋ ํธ์ ๋๋ค. ๋์ฌ์ ์์ด ํ์ ๊ฐ ๋ณ๋์ฑ์ด ํฌ๊ธฐ ๋๋ฌธ์, ํนํ ๊ฐ ์งํ์ด๋ ์ฌ์ฅ ์งํ์ด ๋๋ฐ๋ ํ์์ ๊ฒฝ์ฐ ์น๋ฃ ์ฝ๋ฌผ ๋ชจ๋ํฐ๋ง(TDM)์ด ๊ฐ๋ ฅํ ๊ถ์ฅ๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : The primary mechanism of action involves the competitive inhibition of **phosphodiesterase (PDE)** enzymes. * **PDE Inhibition** โ Decreased breakdown of **cyclic AMP (cAMP)** โ Elevated intracellular cAMP levels. * Increased cAMP โ Enhanced release of endogenous **epinephrine** โ Relaxation of bronchial and pulmonary vascular smooth muscle. * Elevated cAMP also inhibits the release of inflammatory mediators like **histamine** and slow-reacting substance of anaphylaxis (SRS-A) from mast cells. * **Intracellular Calcium Translocation:** Methylxanthines alter intracellular ionized calcium dynamics, contributing to increased diaphragmatic contractility (reducing respiratory fatigue) and weak positive inotropic/chronotropic effects on the heart. * **Additional Effects:** Induces mild diuresis, stimulates the central nervous system (CNS) and respiratory centers, and increases gastric acid secretion.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Bronchodilation (Extended-Release) ยท 20 mg/kg PO once daily in the PM; using Slo-Bid: 25 mg/kg PO once daily in the PM ยท PO ยท q24h ยท Products Theo-Dur and Slo-Bid are no longer available in the USA. Cautious use of dog dose/products is a reasonable alternative.
- Bronchodilation ยท 6.6. mg/kg PO twice daily; using sustained release tablets (Theo-Dur): 25-50 mg (total dose) per cat PO in the evening ยท PO ยท q12h or q24h ยท Using aminophylline tablets or sustained release tablets
- Tracheal collapse (mild clinical signs, <50% collapse) ยท aminophylline: 5 mg/kg PO, two times daily. ยท PO ยท q12h
- Bronchoconstriction associated with fulminant CHF ยท Aminophylline 4-8 mg/kg SC, IM, IV q8-12h. ยท SC/IM/IV ยท q8-12h
- Cough ยท Aminophylline: 5 mg/kg PO twice daily ยท PO ยท q12h
- Bronchodilation ยท 4.25 mg/kg PO 2-3 times a day ยท PO ยท q8-12h
- Pulmonary edema ยท Aminophylline 2-7 mg/kg IV q6-12h; Theophylline 5-15 mg/kg PO q12h ยท IV/PO ยท q6-12h ยท IV aminophylline should be diluted in at least 100 mL of D5W or normal saline and administered slowly (not >25 mg/min).
- Pulmonary edema ยท 11 mg/kg PO or IV q8-12h. ยท PO/IV ยท q8-12h ยท To 'load' may either double the initial dose or give both oral and IV dose at the same time. IV infusion in ~1L fluids over 20-60 mins.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to any xanthines (including theobromine or caffeine)
- Hypersensitivity to ethylenediamine (specific to aminophylline)
์ด์๋ฐ์
- Nausea and vomiting
- Diarrhea
- Insomnia / Restlessness
- Polyphagia (increased appetite)
- Polydipsia and polyuria (increased thirst and urination)
- Tachycardia (rapid heart rate)
- Nervousness, excitability, and tremors (especially in horses)
- Diaphoresis (sweating in horses)
- Ataxia
- Seizures (in severe toxicity)
- Cardiac dysrhythmias (in severe toxicity)
์ฝ๋ฌผ ์ํธ์์ฉ
- Phenobarbital ยท May decrease theophylline levels via hepatic enzyme induction.
- Fluoroquinolones (e.g., enrofloxacin, ciprofloxacin) ยท Can significantly increase theophylline levels. Consider reducing theophylline dose by 30% and monitor for toxicity.
- Macrolides (e.g., erythromycin, clindamycin, lincomycin) ยท Can increase theophylline levels.
- Cimetidine ยท Can increase theophylline levels by inhibiting hepatic metabolism.
- Ketamine ยท Concurrent use can cause an increased incidence of seizures.
- Halothane ยท Concurrent use may cause an increased incidence of cardiac dysrhythmias.
- Sympathomimetics (e.g., ephedrine, isoproterenol) ยท Toxic synergism; can lead to severe cardiac arrhythmias.
- Beta-blockers (non-selective, e.g., propranolol) ยท Can increase theophylline levels and antagonize bronchodilatory effects.
- Corticosteroids ยท Can increase theophylline levels.
๋ชจ๋ํฐ๋ง
- Therapeutic efficacy (improvement in breathing/cough)
- Clinical signs of toxicity (GI upset, CNS stimulation, tachycardia)
- Serum trough levels at steady state (Target: >8-10 mcg/mL in small animals; do not exceed 15 mcg/mL in horses. Human therapeutic range is 10-20 mcg/mL)
๊ณผ์ฉ๋
Clinical signs of toxicity are usually associated with serum levels **greater than 20 mcg/mL** in humans, though dogs appear to tolerate higher levels. **Life-threatening signs:** * Tachycardia and severe cardiac arrhythmias * CNS effects including seizures and hyperthermia **Treatment is supportive:** * **Decontamination:** Empty the gut, administer activated charcoal and a cathartic if oral ingestion was recent. * **Seizures:** Maintain an adequate airway and treat with IV **diazepam**. * **Monitoring:** Continuous ECG monitoring for arrhythmias. Monitor and correct fluid/electrolyte imbalances. * **Symptomatic Care:** Hyperthermia may be treated with phenothiazines; severe tachycardia may be treated with **propranolol** if life-threatening.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.